OSIP 339391(748136-54-1)
- Name: OSIP 339391
- Synonyms:OSIP 339391;N-[2-[[2-phenyl-6-[4-(3-phenyl-2,2,3,3-tetratritiopropyl)piperazine-1-carbonyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]ethyl]acetamide
- Molecular Formula:C30H31N7O2T4
- Molecular Weight:533.67703707
- CAS Registry Number:748136-54-1
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 1116571-01-7/1-Piperazinecarboximidamide, N'-(3-bromophenyl)-N-cyano-2-methyl-4-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (2S)-
- 1082743-32-5/4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1-cyclopentyl-1,5-dihydro-6-[(3S,4S)-4-methyl-1-(6-quinoxalinylmethyl)-3-pyrrolidinyl]-
- 1197300-24-5/4-Isoxazolecarboxamide, 3-(2-chlorophenyl)-N-(4-chlorophenyl)-N,5-dimethyl-
- 1262406-02-9/2-Benzothiazolamine, N-propyl-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 1262406-08-5/6H-Pyrazolo[3,4-b]pyridin-6-one, 1,7-dihydro-4-(trifluoromethyl)-3-[3-(trifluoromethyl)phenyl]-
- 1245527-15-4/1H-Pyrrolo[2,3-c]pyridine-2-ethanol, α-[2-[2-methoxy-5-(5-pyrimidinyl)phenyl]-2-methylpropyl]-α-(trifluoromethyl)-, (αR)-
- 1245526-82-2/Glucocorticoid receptor agonist
- 1146395-46-1/Benzeneacetamide, 4-(3-methyl-2-pyrazinyl)-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]-
- 1021298-13-4/Methanone, [4-methyl-3-(1-pyrrolidinylsulfonyl)phenyl](octahydro-2(1H)-isoquinolinyl)-
- 887289-02-3/Benzamide, N-[2-(cyclopropylmethyl)-5-(1,1-dimethylethyl)-1,2-dihydro-1-methyl-3H-pyrazol-3-ylidene]-2-fluoro-3-(trifluoromethyl)-
- 1173435-64-7/BMS 665053
- 919482-44-3/2H-Benzimidazol-2-one, 1-[(2R)-2,3-dihydroxypropyl]-1,3-dihydro-3-[1-[(1R,3S,4S)-spiro[bicyclo[2.2.1]heptane-2,1'-cyclopropan]-3-ylmethyl]-4-piperidinyl]-
- 748136-54-1/OSIP 339391
- 917987-68-9/[3H]PSB-298
- 1029401-88-4/1H-Pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione, 6-[4-[2-[4-(5-chloro-2-benzothiazolyl)-1-piperazinyl]-1,1-dimethyl-2-oxoethoxy]phenyl]-1,3-dimethyl-
- 46155-90-2/1H-Purine-2,6-dione, 3,4,5,9-tetrahydro-1,3-dimethyl-
- 1057677-92-5/2-(6-(4-(4-benzylphthalazin-1-yl)piperazin-1-yl)pyridin-3-yl)propan-2-ol
- 720690-73-3/GSK 189254A
- 1158838-43-7/Aurora A inhibitor II
- 861392-99-6/Benzeneacetamide, 4-chloro-N-[1-[[(cyanoamino)[(2-methyl-3-pyridinyl)imino]methyl]amino]-2,2-dimethylpropyl]-
- 1067647-43-1/1H-Indole-2,4-dione, 3-[2,5-dihydro-3-methyl-5-oxo-1-[4-(trifluoromethoxy)phenyl]-1H-pyrazol-4-yl]-3,5,6,7-tetrahydro-6,6-dimethyl-1-phenyl-3-(trifluoromethyl)-
- 145148-39-6/3-PiperidinaMine, N-[(2-Methoxyphenyl)Methyl]-2-phenyl-, (Hydrochloride) (1:2), (2S,3S)-
- 909106-60-1/A 876828
- 909106-97-4/A 924825
- 700874-71-1/LY2109761
- 1025720-94-8/N-[4-[(2-Amino-3-chloropyridin-4-yl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide
- 1003883-60-0/1,2-Pyrrolidinedicarboxamide, N1-(4-chlorophenyl)-N2-[(4-chlorophenyl)methyl]-N2-(2-hydroxyethyl)-, (2R)-
- 1003882-41-4/1,2-Pyrrolidinedicarboxamide, N2-[(4-chlorophenyl)methyl]-N2-methyl-N1-[4-(trifluoromethyl)phenyl]-, (2R)-
- 212790-31-3/CP 481715
- 864947-20-6/3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[1-(cyclopropylmethyl)-2,3-dioxo-3-(2-propen-1-ylamino)propyl]-3-[(2S)-2-[[[[(1S)-1-[(4,4-dimethyl-2,6-dioxo-1-piperidinyl)methyl]-2,2-dimethylpropyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-